This site is intended for UK Healthcare Professionals only


June 2023

Welcome to our NDD Community

A resource centre for healthcare professionals working in neurodevelopmental disorders such as Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, and learning disabilities

Attention Deficit Hyperactivity Disorder (ADHD): Flynn has been directly involved in the field of ADHD for over ten years. During this time we have sought to raise awareness of the condition and its impact on the individual, with the aim of bringing about positive change to those whose lives are affected by the diagnosis.

Autism Spectrum Disorder (ASD): We work with leading experts in the field to design meeting programmes that explore key issues in ASD whilst offering practical tips and training that are applicable for use in the real world.

Smith-Magenis Syndrome (SMS): Flynn has collaborated with clinicians and leaders working within the NHS and elsewhere to create a range of healthcare professional and patient-focussed resources to support the patient journey.

Latest Events

We are committed to the delivery of high quality education and supporting the continued development of healthcare professionals - it's our way of helping you to help your patients. Here are the latest educational events across our community.

Featured Event

Become an NDD Community Member

Join our community as a Member and keep up to date on the latest developments.

Latest Education and Training

Free resources for HCPs and patient information across neurodevelopmental disorders. Resources are fully searchable and categorised by therapy area, condition, format and products.

Insomnia in paediatric ASD

An interactive case study for healthcare professionals exploring why insomnia in ASD is a priority, the importance of sleep and how to achieve positive outcomes.

4 Reasons to Stop Prescribing Liquid Melatonin for Children

There is a general acceptance of the benefits of solid dosage forms over liquid dosage forms for stability, dosing, and administration issues1. This booklet provides healthcare professionals with a concise summary of the drawbacks of prescribing liquid melatonin in children, with the support of clinical data. 1. European Medicines Agency, Guideline on pharmaceutical development of medicines for paediatric use, 2013. (Accessed November 2022)

Slenyto® (Prolonged release melatonin) Placebo Dose Card

A paediatric dose card illustrating the range of presentations for Slenyto®

To request this material please contact us.

Request a meeting

Send a virtual meeting request

'ART' - The ADHD Referral Toolkit

‘ART’ – the ADHD Referral Toolkit - is a primary care toolkit designed to improve the quality of ADHD referrals to secondary care. This resource is available to all UK primary care clinicians. In this video Dr Jeremy Mudunkotuwe, Consultant Psychiatrist, Surrey and Borders NHS Foundation Trust and Dr Nina Champaneri, Consultant Child and Adolescent Psychiatrist, in the Forward-Thinking Birmingham Crisis and Home Treatment Team provide information on the tool’s availability and its applicability for primary care.

ART is a bespoke EMIS and SystmOne protocol which helps primary care clinicians to:

  • assess patients who present with the symptoms of ADHD
  • decide if the patient should be referred for further assessment by a specialist
  • generate a referral letter by automatically collating key information into a letter template

This video gives an overview of the referral toolkit and outlines the benefits of it to both the NHS and the patient.

ART is provided as a service to medicine by Flynn Pharma Ltd.